AI Article Synopsis
- Monitoring immunosuppressive drugs (ISDs) in blood is crucial for ensuring patient safety and treatment efficacy due to the narrow therapeutic ranges and potential side effects associated with these medications.
- Accurate and precise measurements are essential for avoiding drug underexposure or overexposure, which can lead to serious health risks.
- This overview from the Immunosuppressive Drugs Scientific Committee aims to provide a summary and guidance on the best practices for therapeutic drug monitoring (TDM) of ISDs.
Article Abstract
Monitoring immunosuppressive drugs (ISDs) in blood or plasma is still a key therapeutic drug monitoring (TDM) application in clinical settings. Narrow target ranges and severe side effects at drug underexposure or overexposure make accurate and precise measurements a must. This overview prepared by the Immunosuppressive Drugs Scientific Committee of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology is intended to serve as a summary and guidance document describing the current state-of-the-art in the TDM of ISDs.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/FTD.0000000000000269 | DOI Listing |
Publication Analysis
Top Keywords
therapeutic drug
12
drug monitoring
12
immunosuppressive drug
8
international association
8
association therapeutic
8
monitoring clinical
8
clinical toxicology
8
scientific committee
8
immunosuppressive drugs
8
drug
6
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!